BeyondSpring BYSI
NASDAQ BYSI
$0.77 +0.16 (+25.70%)
At close: Sep 10, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Net Shares Issued and Repurchased (2020 - 2026)

BeyondSpring's (BYSI) quarterly Net Shares Issued and Repurchased came in at $183624.0 in Q2 2026, down 18.3% year-over-year from $224750.0 in Q2 2025, and down 71.36% quarter-over-quarter from $641249.0 in Q1 2026.

Analysis

BeyondSpring (BYSI) Net Shares Issued and Repurchased (2020 - 2026) Analysis & Trends

BeyondSpring has disclosed Net Shares Issued and Repurchased across 6 years of filings, most recently posting $183624.0 for Q2 2026.

  • In Q2 2026, Net Shares Issued and Repurchased fell 18.3% year-over-year to $183624.0; the TTM figure through Jun 2026 stood at $183624.0 (down 18.3% YoY), while the FY2025 annual figure was $375344.0, down 42.37% from the prior year.
  • Net Shares Issued and Repurchased came in at $183624.0 for Q2 2026 at BeyondSpring, down from $641249.0 in the prior quarter.
  • In the past five years, Net Shares Issued and Repurchased ranged from a high of $1.3 million in Q4 2022 to a low of $4500.0 in Q1 2025.
  • Average Net Shares Issued and Repurchased over 4 years is $480257.1, with a median of $375344.0 recorded in 2025.
  • Year-over-year, Net Shares Issued and Repurchased sank 42.37% in 2025 and surged 14149.98% in 2026.
  • Over 4 years, Net Shares Issued and Repurchased stood at $1.3 million in 2022, then sank by 49.15% to $651333.0 in 2024, then slumped by 42.37% to $375344.0 in 2025, then sank by 51.08% to $183624.0 in 2026.
  • Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $183624.0 in Q2 2026, $641249.0 in Q1 2026, and $375344.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn -
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn -
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -3.07 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn -
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn -
7 Revolution Medicines 42.88 Bn 42.88 Bn - -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn -
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn -
10 BeyondSpring 31.51 Mn 31.51 Mn - 183,624.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 183,624.00
Mar 31, 2026 641,249.00
Dec 31, 2025 375,344.00
Jun 30, 2025 224,750.00
Mar 31, 2025 4,500.00
Dec 31, 2024 651,333.00
Dec 31, 2022 1.28 Mn
Sep 30, 2021 153,000.00
Jun 30, 2021 801,291.00
Mar 31, 2020 381,301.00